BioSante Pharmaceuticals (BPAX +5.1%) pops after the company releases specific data from a study...

|By:, SA News Editor

BioSante Pharmaceuticals (BPAX +5.1%) pops after the company releases specific data from a study on its LibiGel testosterone gel. The report supports earlier claims that the treatment successfully increased free-testosterone levels in postmenopausal women.